Analysis performed by the NRC
- Confirmation of bacterial identification to species level using MALDI-TOF MS
- Screening of antimicrobial resistance mechanisms by in vitro susceptibility testing to 16 antimicrobial drugs using disc diffusion
- Determination of MICs by broth microdilution method according the CLSI guidelines and interpretative breakpoints
- Carbapenem hydrolysis-based tests
- Inhibitors-based combination disk tests:
- For the detection of ESBL and/or hyperproduced AmpC
- For the detection of carbapenemase
- Extended susceptibility disk diffusion testing against aminoglycosides for the detection of 16S rRNA methylases
- Loop mediated isothermal amplification (LAMP) targeting NDM, VIM, OXA-48, OXA-181, KPC and CTX-M group 1 and 9
- End-point PCR simplex or multiplex targetting
- carbapenemases (NDM, VIM, KPC, IMP, OXA-48, OXA-427, BES, IMI, SIM, GIM, DIM, FIM, SMB, SME, SPM)
- oxacillinase carbapenemase (OXA-group23, -group 24 and -58)
- minor ESBL (GES, VEB, PER and BEL)
- oxacillinase group (OXA-1,OXA-2,OXA-9,OXA-10, OXA-18,OXA-20 and OXA-198)
- ESBL (TEM, SHV and PME )
- 16S rRNA methylases (ArmA, Rmt A-B-C-D-E-F-G, NpmA)
- plasmid-borne quinolone resistance genes (QnrA, QnrB, QnrS)
- DNA microarray
- Check-MDR assays targeting ESBL and carbapenemases genes
- Other genetic characterization methods:
- Sequencing of resistance genes and the genetic environment
- Plasmid extraction by Kieser method
- Conjugation, transformation and cloning
- PCR-based replicon typing : method based on replicons (Inc/rep PCR) of the major plasmid incompatibility groups (Caratolli A. et al , JAC. 2010 Dec;65(12):2518-29)
